Increased severity of renal impairment in nephritic mice lacking the EP1 receptor

Canadian Journal of Physiology and Pharmacology

Volumn 84, Issue 8-9, 2006, Pages 877-885

  Rahal, Sherine ^a,b   McVeigh, Lyne I ^a,b   Zhang, Yahua ^c   Guan, Youfei ^c   Breyer, Matthew D ^c   Kennedy, Chris R J ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

EP1 receptor; Nephritis; Prostaglandin E2

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CREATININE; E PROSTANOID RECEPTOR1; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM ION; PROSTAGLANDIN E2; PROSTANOID RECEPTOR; SODIUM ION; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY INJURY; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEINURIA; URINE OSMOLALITY;

ALBUMINURIA; ALDOSTERONE; ANIMALS; ANTIBODIES; CREATININE; FEMALE; GLOMERULAR BASEMENT MEMBRANE; GLOMERULONEPHRITIS; IMMUNE SERA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POTASSIUM; RECEPTORS, PROSTAGLANDIN E; UREA;

EID: 33846371954     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y06-029     Document Type: Article

References (47)

1. Arisz, L., Donker, A.J., Brentjens, J.R., and van der Hem, G.K. 1976. The effect of indomethacin on proteinuria and kidney function in the nephrotic syndrome. Acta Med. Scand. 199: 121-125. PMID:1251764.
2. Bek, M., Nusing, R., Koward, P., Henger, A., Mundel, P., and Pavenstadt, H. 1999. Characterization of prostanoid receptors in podocytes. J. Am. Soc. Nephrol. 10: 2084-2093. PMID:10505684.
3. Bergstein, J.M. 1991. Prostaglandin inhibitors in the treatment of nephrotic syndrome. Pediatr. Nephrol. 5: 335-338. doi:10.1007/BF00867497. PMID:1867990.
4. Bird, J.E., Giancarli, M.R., Kurihara, T., Kowala, M.C., Valentine, M.T., Gitlitz, P.H., et al. 2000. Increased severity of glomerulonephritis in C-C chemokine receptor 2 knockout mice. Kidney Int. 57: 129-136. doi:10.1046/j.1523-1755.2000. 00848.x. PMID:10620194.
5. Blume, C., Heise, G., Muhlfeld, A., Bach, D., Schror, K., Gerhardz, C.D., et al. 1999. Effect of flosulide, a selective cyclooxygenase 2 inhibitor, on passive heymann nephritis in the rat. Kidney Int. 56: 1770-1778. doi:10.1046/j.1523-1755.1999. 00742.x. PMID:10571785.
6. Braam, B., Mitchell, K.D., Koomans, H.A., and Navar, L.G. 1993. Relevance of the tubuloglomerular feedback mechanism in pathophysiology. J. Am. Soc. Nephrol. 4: 1257-1274. PMID:8130353.
7. Breyer, M.D., and Breyer, R.M. 2000. Prostaglandin E receptors and the kidney. Am. J. Physiol. Renal Physiol. 279: F12-F23. PMID:10894784.
8. Breyer, M.D., and Breyer, R.M. 2001. G protein-coupled prostanoid receptors and the kidney. Annu. Rev. Physiol. 63: 579-605. doi:10.1146/annurev.physiol.63.1.579. PMID:11181968.
9. Breyer, R.M., Bagdassarian, C.K., Myers, S.A., and Breyer, M.D. 2001. Prostanoid receptors: subtypes and signaling. Annu. Rev. Pharmacol. Toxicol. 41: 661-690. doi:10.1146/annurev. pharmtox.41.1.661. PMID:11264472.
10. Coleman, R.A., Smith, W.L., and Narumiya, S. 1994. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46: 205-229. PMID:7938166.
11. Conte, J., Suc, J.M., and Mignon-Conte, M. 1967. Anti-proteinuric effect of indomethacin in glomerulopathies (nephrotic syndrome, acute glomerulonephritis and chronic glomerulonephritis). Preliminary note. J. Urol. Nephrol. (Paris), 73: 850-856. PMID:5596281.
12. Epstein, M. 2002. Non-steroidal anti-inflammatory drugs and the continuum of renal dysfunction. J. Hypertens. Suppl. 20: S17-S23. PMID:12683423.
13. Fitzgerald, G.A. 2004. Coxibs and cardiovascular disease. N. Engl. J. Med. 351: 1709-1711. doi:10.1056/NEJMp048288. PMID:15470192.
14. Fleming, E.F., Athirakul, K., Oliverio, M.I., Key, M., Goulet, J., Koller, B.H., and Coffman, T.M. 1998. Urinary concentrating function in mice lacking EP3 receptors for prostaglandin E2. Am. J. Physiol. 275: F955-F961. PMID:9843913.
15. Guan, Y., Zhang, Y., Breyer, R.M., Flowler, B., Davis, L., Hebert, R.L., and Breyer, M.D. 1998. Prostaglandin E2 inhibits renal collecting duct Na+ absorption by activating the EP1 receptor. J. Clin. Invest. 102: 194-201. PMID:9649573.
16. Hilton, P.J., Jones, N.F., Barraclough, M.A., and Lloyd-Davies, R.W. 1969. Urinary osmolality in acute renal failure due to glomerulonephritis. Lancet, 2: 655-656. PMID:4185406.
17. Homma, S., Takeda, S., Kusano, E., Matsuo, Y., Shimizu, T., Nakamura, M., et al. 2002. Impaired urinary concentrating ability in genetically polyuric mice. Nephron, 92: 889-897. doi:10. 1159/000065463. PMID:12399636.
18. Hull, M.A., Ko, S.C., and Hawcroft, G. 2004. Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer? Mol. Cancer Ther. 3: 1031-1039. PMID:15299086.
19. Ishibashi, R., Tanaka, I., Kotani, M., Muro, S., Goto, M., Sugawara, A., et al. 1999. Roles of prostaglandin E receptors in mesangial cells under high-glucose conditions. Kidney Int. 56: 589-600. doi:10.1046/j.1523- 1755.1999.00566.x. PMID:10432398.
20. Kaizu, K., Marsh, D., Zipser, R., and Glassock, R.J. 1985. Role of prostaglandins and angiotensin II in experimental glomerulonephritis. Kidney Int. 28: 629-635. PMID:3866874.
21. Karkar, A.M., and Rees, A.J. 1997. Influence of endotoxin contamination on anti-GBM antibody induced glomerular injury in rats. Kidney Int. 52: 1579-1583. PMID:9407503.
22. Kawamori, T., Kitamura, T., Watanabe, K., Uchiya, N., Maruyama, T., Narumiya, S., et al. 2005. Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development. Carcinogenesis, 26: 353-357. PMID:15564292.
23. Kennedy, C.R., Xiong, H., Rahal, S., Vanderluit, J., Slack, R.S., Zhang, Y., Guan, Y., Breyer, M.D. and Hebert, R.L. 2006. Urine concentrating defect in prostaglandin EP1-deficient mice. Am. J. Physiol. Renal Physiol. In press.
24. Lianos, E.A., Andres, G.A., and Dunn, M.J. 1983. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics. J. Clin. Invest. 72: 1439-1448. PMID:6685136.
25. Ma, W., and Quirion, R. 2005. Up-regulation of interleukin-6 induced by prostaglandin E from invading macrophages following nerve injury: an in vivo and in vitro study. J. Neurochem. 93: 664-673. doi:10.1111/j.1471-4159.2005. 03050.x. PMID:15836625.
26. Makino, H., Tanaka, I., Mukoyatna, M., Sugawara, A., Mori, K., Muro, S., et al. 2002. Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist. J. Am. Soc. Nephrol. 13: 1757-1765. doi:10.1097/01.ASN.0000019782. 37851.BF. PMID:12089371.
27. Masaki, T., Chow, F., Nikolic-Paterson, D.J., Atkins, R.C., and Tesch, G.H. 2003. Heterogeneity of antigen expression explains controversy over glomerular macrophage accumulation in mouse glomerulonephritis. Nephrol. Dial. Transplant. 18: 178-181. PMID:12480978.
28. Matsuoka, Y., Furuyashiki, T., Bito, H., Ushikubi, F., Tanaka, Y., Kobayashi, T., et al. 2003. Impaired adrenocorticotropic hormone response to bacterial endotoxin in mice deficient in prostaglandin E receptor EP1 and EP3 subtypes. Proc. Natl. Acad. Sci. U.S.A. 100: 4132-4137. doi:10.1073/pnas.0633341100. PMID:12642666.
29. Murray, M.D., and Brater, D.C. 1997. Effects of NSAIDs on the kidney. Prog. Drug Res. 49: 155-171. PMID:9388387.
30. Nagai, H., Yamada, H., Nishigaki, T., Nakazawa, M., and Koda, A. 1985. The susceptibility of experimental glomerulonephritis in six different strains of mice. J. Pharmacobiodyn. 8: 586-589. PMID:2933507.
31. Nihei, T., Miura, Y., and Yagasaki, K. 2001. Inhibitory effect of resveratrol on proteinuria, hypoalbuminemia and hyperlipidemia in nephritic rats. Life Sci. 68: 2845-2852. doi:10.1016/S0024-3205(01)01061-X. PMID:11432450.
32. Pasero, G., Corsini, G., Palia, R., and Rindi, P. 1974. Proteinuria-lowering effect of anti-inflammatory drugs. Curr. Med. Res. Opin. 2: 270-274. PMID:4415353.
33. Sakai, T., Harris, F.H., Jr., Marsh, D.J., Bennett, C.M., and Glassock, R.J. 1984. Extracellular fluid expansion and autoregulation in nephrotoxic serum nephritis in rats. Kidney Int. 25: 619-628. PMID:6482166.
34. Schreiner, G.F., Cotran, R.S., Pardo, V., and Unanue, E.R. 1978. A mononuclear cell component in experimental immunological glomerulonephritis. J. Exp. Med. 147: 369-384. doi:10.1084/jem.147.2.369. PMID:146726.
35. Sessa, A., Cioffi, A., Conte, F., Saruggia, M., Di Belgiojoso, G.B., and Donati, M.B. 1978. Indomethacin and lysine acetylsalicylate in rats with autologous nephrotoxic serum nephritis. Biochemical and morphological studies. Nephron, 22: 439-453. PMID:740108.
36. Shehadeh, I.H., Demers, L.M., Abt, A.B., and Schoolwerth, A.C. 1979. Indomethacin and the nephrotic syndrome. JAMA, 241: 1264-1266. doi:10.1001/jama.241.12.1264. PMID:762792.
37. Shimura, N. 1993. Urinary arginine vasopressin (AVP) measurement in children: water deprivation test incorporating urinary AVP. Acta Paediatr. Jpn. 35: 320-324. PMID:8379325.
38. Stock, J.L., Shinjo, K., Burkhardt, J., Roach, M., Taniguchi, K., Ishikawa, T., et al. 2001. The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure. J. Clin. Invest. 107: 325-331. PMID:11160156.
39. Suganami, T., Mori, K., Tanaka, I., Mukoyama, M., Sugawara, A., Makino, H., et al. 2003. Role of prostaglandin E receptor EP1 subtype in the development of renal injury in genetically hypertensive rats. Hypertension, 42: 1183-1190. doi:10.1161/01.HYP. 0000101689.64849.97. PMID:14670979.
40. Takahashi, K., Schreiner, G.F., Yamashita, K., Christman, B.W., Blair, I., and Badr, K.F. 1990. Predominant functional roles for thromboxane A2 and prostaglandin E2 during late nephrotoxic serum glomerulonephritis in the rat. J. Clin. Invest. 85: 1974-1982. PMID:2347921.
41. Tan, S.Y., Shapiro, R., Franco, R., Stockard, H., and Mulrow, P.J. 1979. Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism. Ann. Intern. Med. 90: 783-785. PMID:434681.
42. Unanue, E.R., and Dixon, F.J. 1967. Experimental glomerulonephritis: immunological events and pathogenetic mechanisms. Adv. Immunol. 6: 1-90. PMID:4860246.
43. Vane, J.R., and Botting, R.M. 2003. The mechanism of action of aspirin. Thromb. Res. 110: 255-258. doi:10.1016/S0049-3848(03)00379-7. PMID:14592543.
44. Velosa, J.A., and Torres, V.E. 1986. Benefits and risks of nonsteroidal antiinflammatory drugs in steroid-resistant nephrotic syndrome. Am. J. Kidney Dis. 8: 345-350. PMID:3788972.
45. Vriesendorp, R., Donker, A.J., de Zeeuw, D., de Jong, P.E., and van der Hem, G.K. 1985. Antiproteinuric effect of naproxen and indomethacin. A double-blind crossover study. Am. J. Nephrol. 5: 236-242. PMID:3901756.
46. Whelton, A. 1999. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am. J. Med. 106: 5B, 13S-24S. doi:10.1016/S0002-9343(99) 00113-8. PMID:10390124.
47. Yao, L., Huang, D.Y., Pfaff, I.L., Nie, X., Leitges, M., and Vallon, V. 2004. Evidence for a role of protein kinase C-alpha in urine concentration. Am. J. Physiol. Renal Physiol. 287: F299-F304. doi:10.1152/ajprenal.00274. 2003. PMID:15039142.